NEOLA — Neola Medical AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK175.38m
- SEK155.82m
- 10
- 14
- 50
- 12
Annual cashflow statement for Neola Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.72 | -6.65 | -10.4 | -9.01 | -10.1 |
| Depreciation | |||||
| Non-Cash Items | 0.001 | 0.016 | 1.07 | 1.81 | 1.59 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.634 | -0.309 | 0.786 | 0.658 | -2.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.08 | -6.93 | -8.5 | -6.54 | -10.8 |
| Capital Expenditures | -2.17 | -10.5 | -11.6 | -12.3 | -11.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -2.17 | -10.5 | -11.6 | -12.3 | -11.2 |
| Financing Cash Flow Items | -2.96 | — | — | -0.168 | -0.069 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 19.5 | 23.7 | 37.2 | 0.336 | 19.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.3 | 6.29 | 17.1 | -18.5 | -2.02 |